References
Dehdashti F, Grigsby PW, Myerson RJ et al (2013) Positron emission tomography with [18F]-3′-deoxy-3′fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study. Mol Imag Biol 15:106–113
Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474
Engstrom PF, Arnoletti JP, Benson AB 3rd et al (2009) Rectal cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 7:838–881
Valentini V, Aristei C, Glimelius B et al (2009) Multidisciplinary rectal cancer management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 92:148–163
Vecchio FM, Valentini V, Minsky BD et al (2005) The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Physics 62:752–760
Mandard AM, Dalibard F, Mandard JC et al (1004) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73:2680–2686
Janssen MH, Öllers MC, Riedl RG et al (2010) Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using 18F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging. Int J Rad Oncol Biol Physics 77:392–399
Chalkidou A, Landau DB, Odell EW et al (2012) Correlation between Ki-67 immunohistochemistry and 18F-Fluorothymidine uptake in patients with cancer: a systematic review and meta-analysis. Eur J Cancer 48:3499–3513
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chalkidou, A., Mikhaeel, G., O’Doherty, M.J. et al. Letter to the Editor re: Positron Emission Tomography with [18F]-3′-Deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study. Mol Imaging Biol 15, 521–522 (2013). https://doi.org/10.1007/s11307-013-0628-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-013-0628-9